The psychology is straightforward: similar names, similar active ingredients, and significantly lower prices create an assumption of equivalence
According to Dosz, the natural products industry and scientific community are focusing more on real-world measures such as proven biomarkers, mechanism-based data, and clinical results proving how antioxidants operate through various mechanisms to help prevent oxidative damage
A recent study found that Americans with diabetes, in particular, who consume higher levels of phosphatidylcholine, have an elevated chance of mortality from cardiovascular disease even in the absence of risk factors [5, 55]
The strongest evidence right now is in knee osteoarthritis (the STEP-9 trial) and rheumatoid arthritis (the UCLA cohort), with rapidly growing data in psoriatic arthritis and lupus
But that will only happen if the results are translated into action at the clinical coalface, so thats an important next step